Ibere Pharmaceuticals (UNQ: IBER)
Financials · Capital Markets · US
$—
— today · — 1Y
Ibere Pharmaceuticals (UNQ: IBER) operates in the Capital Markets industry within the Financials sector.
Tweenvest scores Ibere Pharmaceuticals across four factors: quality 25/100. Its strongest factor is quality.
IBER price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- —
- Revenue (TTM)
- —
- P/E
- —
- EPS
- 0.36
- Dividend yield
- —
- Beta (5Y)
- —
- 52-week high
- $—
- 52-week low
- $—
- Avg volume (3M)
- —
- Shares outstanding
- —
- Employees
- —
- Next earnings
- —
About Ibere Pharmaceuticals
Ibere Pharmaceuticals does not have significant operations. It focuses on effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or other similar business combination with one or more businesses. The company was incorporated in 2020 and is based in Philadelphia, Pennsylvania.
- Founded
- 2020
- Exchange
- Unquoted Security
- Currency
- USD
Other Capital Markets companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Global Gaming Technologies Corp.OTCPK: BLKC.F | $122.00 | $0.00 | — |
| Elixxer Ltd.OTCPK: ELIX.F | $95.00 | $0.00 | — |
| Longfin Corp.OTCPK: LFIN | $75.00 | $0.00 | — |
| Polaris Northstar Capital Corp.OTCPK: RSCZ.F | $57.00 | $— | — |
| Chinawe.com Inc.OTCPK: CHWE | $44.00 | $— | — |
| Registered Plan Private Investments Inc.OTCPK: LXGT.F | $27.00 | $0.00 | — |
| Greenwind Holdings Inc.OTCPK: NEWG | $23.00 | $0.00 | — |
| Interups, Inc.OTCPK: ITUP | $7.00 | $— | — |
Figures last refreshed Oct 11, 2026.